Cubist Pharmaceuticals (CBST) 73.73 $CBST
European Antibiotic Awareness Day Highlights Need for Urgent Action
Business Wire - Mon Nov 17, 12:00AM CST
Tuesday, November 18th marks European Antibiotic Awareness Day. Public health experts, hospitals, and physicians in the United Kingdom are uniting to raise awareness of what can be done to fight what the World Health Organization (WHO) calls one of the top three threats to human health. The issue of rising antibiotic resistance and the lack of treatment options is causing increasing concern worldwide, including in the UK.
CBST: 73.73 (+1.00)
5 Things Actavis plc's Management Wants You to Know
George Budwell, The Motley Fool - Motley Fool - Wed Nov 12, 8:21AM CST
The pharmaceutical industry has had a banner year in many ways, fueled by a slew of major drug approvals in recent years, numerous mergers and acquisitions, and significant corporate reorganizations that have helped to boost earnings. The specialty...
DRTX: 24.16 (+0.41), AGN: 213.37 (+4.17), ACT: 269.60 (+21.66), IRWD: 13.40 (+0.17), CBST: 73.73 (+1.00), PFE: 30.59 (+0.27)
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:14AM CST
Cubist Pharmaceuticals (CBST) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
CBST: 73.73 (+1.00)
Cubist Names Dr. Patrick Vink Chief Operating Officer
Business Wire - Wed Nov 05, 6:30AM CST
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Patrick Vink, M.D., M.B.A., currently Senior Vice President and General Manager of Cubist's International Business, has been promoted to Executive Vice President and Chief Operating Officer, effective January 1, 2015.
CBST: 73.73 (+1.00)
Cubist to Present at Jefferies 2014 Healthcare Conference
Business Wire - Mon Nov 03, 8:01AM CST
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Michael Tomsicek, Cubist's SVP & Chief Financial Officer, will present at the Jefferies 2014 Healthcare Conference on Wednesday, November 19, to discuss the company's business activities, financial outlook, and current news.
CBST: 73.73 (+1.00)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 305.56 (+3.14), CBST: 73.73 (+1.00), MDCO: 25.43 (-0.23), SRPT: 15.57 (+0.23), ALXN: 192.37 (+5.59), AMGN: 162.24 (+3.10), CELG: 106.78 (+2.42)
Why We Think Cubist Pharmaceuticals Has Incredible Upside
Main Street Wins - at Seeking Alpha - Wed Oct 29, 3:34AM CDT
CBST: 73.73 (+1.00), PFE: 30.59 (+0.27), MRK: 59.89 (+0.43)
Buy These 5 Breakout Health Care Stocks for Healthy Gains
at The Street - Tue Oct 28, 9:30AM CDT
Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.
PCYC: 137.07 (+1.97), CBST: 73.73 (+1.00), ABAX: 54.61 (-0.05), INCY: 69.64 (-0.06), HUM: 139.29 (+1.82)
3 States With the Worst Hospital Infection Rates
Todd Campbell, The Motley Fool - Motley Fool - Sun Oct 26, 11:02AM CDT
Media attention on hospitals preparedness to contain infection has surged following reports that two healthcare workers at Texas Health Presbyterian Hospital who treated Ebola patient Eric Duncan contracted the virus. But perhaps attention should...
CBST: 73.73 (+1.00)
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 9:00AM CDT
Cubist Pharmaceuticals (CBST) third-quarter 2014 earnings of 58 cents per share were well ahead of the Zacks Consensus Estimate of 36 cents.
MDVN: 108.12 (+1.32), CBST: 73.73 (+1.00), LGND: 54.59 (-2.36), PDLI: 7.97 (+0.16)
5 Unusual-Volume Stocks Poised for Breakouts
at The Street - Thu Oct 23, 8:25AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
CBST: 73.73 (+1.00), ABAX: 54.61 (-0.05), FUN: 46.82 (+0.19), ICFI: 38.04 (-0.22), PEIX: 15.13 (+0.51)
After Yesterday's Rally of 4.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 22, 4:42PM CDT
Cubist Pharmaceuticals (NASDAQ:CBST) traded in a range yesterday that spanned from a low of $65.93 to a high of $69.84. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $67.71 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CBST: 73.73 (+1.00)
Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock
at The Street - Wed Oct 22, 1:30PM CDT
Trade-Ideas LLC identified Cubist Pharmaceuticals (CBST) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
CBST: 73.73 (+1.00)
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 22, 8:27AM CDT
Source: Cubist Demand growth tied to an expanding product lineup and rising inpatient volume at hospitals helped Cubist report third quarter results that mostly impressed investors this week. Cubist's total third quarter sales improved by...
CBST: 73.73 (+1.00), GSK: 46.28 (+0.40)
Cubist beats Street 3Q forecasts
Automated Insights - Tue Oct 21, 3:29PM CDT
LEXINGTON, Mass. (AP) _ Cubist Pharmaceuticals Inc. (CBST) on Tuesday reported third-quarter net income of $22.8 million.
CBST: 73.73 (+1.00)
Cubist Reports Third Quarter 2014 Financial Results
Business Wire - Tue Oct 21, 3:00PM CDT
--Non-GAAP Adjusted Operating Income of $99.1 Million; GAAP Operating Income of $67.8 Million
CBST: 73.73 (+1.00)
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma
PR Newswire - Tue Oct 21, 8:15AM CDT
Investor-Edge has initiated coverage on the following equities: Intrexon Corporation (NYSE: XON), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Sangamo BioSciences Inc. (NASDAQ: SGMO), and Cubist Pharmaceuticals Inc. (NASDAQ: CBST). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, October 20, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 16,399.67, up 0.12% and the NASDAQ Composite closed at 4,316.07, up 1.35%. The S&P 500 finished the session 0.91% higher at 1,904.01. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 716.35, up 1.20%, with the index gaining 11.53% on YTD basis. Register for your complimentary reports on these five stocks at:
CBST: 73.73 (+1.00), SGMO: 11.01 (-0.02), XON: 24.84 (-0.09), SPPI: 7.39 (unch), KERX: 15.54 (+0.36)
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer
Business Wire - Mon Oct 20, 6:30AM CDT
--Kenneth M. Bate to Become Lead Independent Director
CBSTZ: 0.04 (unch), CBST: 73.73 (+1.00)
Wall Street Breakfast: IBM To Unload Semiconductor Unit - Report
Wall Street Breakfast - Seeking Alpha - Mon Oct 20, 5:33AM CDT
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Long idea on ...
PHG: 28.76 (+0.47), PER: 8.66 (-0.14), AAMC: 491.02 (+0.52), YHOO: 51.75 (-0.62), SAP: 68.60 (+1.08), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), CBST: 73.73 (+1.00), IBM: 161.89 (-2.27), SHPG: 210.00 (+4.01), MWW: 4.29 (-0.03), NPSP: 30.68 (+0.77), ABBV: 66.05 (+1.01), MSFT: 48.74 (-0.72), DAVE: 24.44 (-0.23), BABA: 110.81 (-3.44)
Shire may turn acquirer after AbbVie deal collapse
Seeking Alpha - at Seeking Alpha - Sun Oct 19, 8:49AM CDT
CBST: 73.73 (+1.00), SHPG: 210.00 (+4.01), NPSP: 30.68 (+0.77)
European Antibiotic Awareness Day Highlights Need for Urgent Action
Business Wire - Mon Nov 17, 12:00AM CST
Tuesday, November 18th marks European Antibiotic Awareness Day. Public health experts, hospitals, and physicians in the United Kingdom are uniting to raise awareness of what can be done to fight what the World Health Organization (WHO) calls one of the top three threats to human health. The issue of rising antibiotic resistance and the lack of treatment options is causing increasing concern worldwide, including in the UK.
CBST: 73.73 (+1.00)
5 Things Actavis plc's Management Wants You to Know
George Budwell, The Motley Fool - Motley Fool - Wed Nov 12, 8:21AM CST
The pharmaceutical industry has had a banner year in many ways, fueled by a slew of major drug approvals in recent years, numerous mergers and acquisitions, and significant corporate reorganizations that have helped to boost earnings. The specialty...
DRTX: 24.16 (+0.41), AGN: 213.37 (+4.17), ACT: 269.60 (+21.66), IRWD: 13.40 (+0.17), CBST: 73.73 (+1.00), PFE: 30.59 (+0.27)
Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:14AM CST
Cubist Pharmaceuticals (CBST) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
CBST: 73.73 (+1.00)
Cubist Names Dr. Patrick Vink Chief Operating Officer
Business Wire - Wed Nov 05, 6:30AM CST
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Patrick Vink, M.D., M.B.A., currently Senior Vice President and General Manager of Cubist's International Business, has been promoted to Executive Vice President and Chief Operating Officer, effective January 1, 2015.
CBST: 73.73 (+1.00)
Cubist to Present at Jefferies 2014 Healthcare Conference
Business Wire - Mon Nov 03, 8:01AM CST
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Michael Tomsicek, Cubist's SVP & Chief Financial Officer, will present at the Jefferies 2014 Healthcare Conference on Wednesday, November 19, to discuss the company's business activities, financial outlook, and current news.
CBST: 73.73 (+1.00)
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 29, 11:28AM CDT
Quite a few biotech companies fared well i the third quarter with earnings surpassing expectations and guidance being raised.
BIIB: 305.56 (+3.14), CBST: 73.73 (+1.00), MDCO: 25.43 (-0.23), SRPT: 15.57 (+0.23), ALXN: 192.37 (+5.59), AMGN: 162.24 (+3.10), CELG: 106.78 (+2.42)
Why We Think Cubist Pharmaceuticals Has Incredible Upside
Main Street Wins - at Seeking Alpha - Wed Oct 29, 3:34AM CDT
CBST: 73.73 (+1.00), PFE: 30.59 (+0.27), MRK: 59.89 (+0.43)
Buy These 5 Breakout Health Care Stocks for Healthy Gains
at The Street - Tue Oct 28, 9:30AM CDT
Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.
PCYC: 137.07 (+1.97), CBST: 73.73 (+1.00), ABAX: 54.61 (-0.05), INCY: 69.64 (-0.06), HUM: 139.29 (+1.82)
3 States With the Worst Hospital Infection Rates
Todd Campbell, The Motley Fool - Motley Fool - Sun Oct 26, 11:02AM CDT
Media attention on hospitals preparedness to contain infection has surged following reports that two healthcare workers at Texas Health Presbyterian Hospital who treated Ebola patient Eric Duncan contracted the virus. But perhaps attention should...
CBST: 73.73 (+1.00)
Cubist Pharmaceuticals' Q3 Earnings Beat Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 9:00AM CDT
Cubist Pharmaceuticals (CBST) third-quarter 2014 earnings of 58 cents per share were well ahead of the Zacks Consensus Estimate of 36 cents.
MDVN: 108.12 (+1.32), CBST: 73.73 (+1.00), LGND: 54.59 (-2.36), PDLI: 7.97 (+0.16)
5 Unusual-Volume Stocks Poised for Breakouts
at The Street - Thu Oct 23, 8:25AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
CBST: 73.73 (+1.00), ABAX: 54.61 (-0.05), FUN: 46.82 (+0.19), ICFI: 38.04 (-0.22), PEIX: 15.13 (+0.51)
After Yesterday's Rally of 4.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 22, 4:42PM CDT
Cubist Pharmaceuticals (NASDAQ:CBST) traded in a range yesterday that spanned from a low of $65.93 to a high of $69.84. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $67.71 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CBST: 73.73 (+1.00)
Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's "Storm The Castle" Stock
at The Street - Wed Oct 22, 1:30PM CDT
Trade-Ideas LLC identified Cubist Pharmaceuticals (CBST) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
CBST: 73.73 (+1.00)
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 22, 8:27AM CDT
Source: Cubist Demand growth tied to an expanding product lineup and rising inpatient volume at hospitals helped Cubist report third quarter results that mostly impressed investors this week. Cubist's total third quarter sales improved by...
CBST: 73.73 (+1.00), GSK: 46.28 (+0.40)
Cubist beats Street 3Q forecasts
Automated Insights - Tue Oct 21, 3:29PM CDT
LEXINGTON, Mass. (AP) _ Cubist Pharmaceuticals Inc. (CBST) on Tuesday reported third-quarter net income of $22.8 million.
CBST: 73.73 (+1.00)
Cubist Reports Third Quarter 2014 Financial Results
Business Wire - Tue Oct 21, 3:00PM CDT
--Non-GAAP Adjusted Operating Income of $99.1 Million; GAAP Operating Income of $67.8 Million
CBST: 73.73 (+1.00)
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma
PR Newswire - Tue Oct 21, 8:15AM CDT
Investor-Edge has initiated coverage on the following equities: Intrexon Corporation (NYSE: XON), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Sangamo BioSciences Inc. (NASDAQ: SGMO), and Cubist Pharmaceuticals Inc. (NASDAQ: CBST). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, October 20, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 16,399.67, up 0.12% and the NASDAQ Composite closed at 4,316.07, up 1.35%. The S&P 500 finished the session 0.91% higher at 1,904.01. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 716.35, up 1.20%, with the index gaining 11.53% on YTD basis. Register for your complimentary reports on these five stocks at:
CBST: 73.73 (+1.00), SGMO: 11.01 (-0.02), XON: 24.84 (-0.09), SPPI: 7.39 (unch), KERX: 15.54 (+0.36)
Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer
Business Wire - Mon Oct 20, 6:30AM CDT
--Kenneth M. Bate to Become Lead Independent Director
CBSTZ: 0.04 (unch), CBST: 73.73 (+1.00)
Wall Street Breakfast: IBM To Unload Semiconductor Unit - Report
Wall Street Breakfast - Seeking Alpha - Mon Oct 20, 5:33AM CDT
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Long idea on ...
PHG: 28.76 (+0.47), PER: 8.66 (-0.14), AAMC: 491.02 (+0.52), YHOO: 51.75 (-0.62), SAP: 68.60 (+1.08), SPY: 205.55 (+1.18), QQQ: 103.68 (+0.77), CBST: 73.73 (+1.00), IBM: 161.89 (-2.27), SHPG: 210.00 (+4.01), MWW: 4.29 (-0.03), NPSP: 30.68 (+0.77), ABBV: 66.05 (+1.01), MSFT: 48.74 (-0.72), DAVE: 24.44 (-0.23), BABA: 110.81 (-3.44)
Shire may turn acquirer after AbbVie deal collapse
Seeking Alpha - at Seeking Alpha - Sun Oct 19, 8:49AM CDT
CBST: 73.73 (+1.00), SHPG: 210.00 (+4.01), NPSP: 30.68 (+0.77)
